Liminatus Pharma, Inc. Class A Common Stock

LIMN · NASDAQ
Analyze with AI
$0.7835+$0.0206 (+2.7%)
At close:Dec 16, 2025, 9:00 PM UTC
$0.807+$0.0235 (+3%)
After hours:Dec 17, 2025, 6:10 AM UTC
P/E TTM-8.21
P/B TTM-12.86
P/S TTM0
Dividend Yield0%
EPS-$0.16
Beta0.376
Valuation
PEG Ratio-11.28
FCF Yield-48.93%
EV / EBITDA-9.30
Quality
ROIC2,943.12%
Gross Margin0.00%
Cash Conv. Ratio4.02
Growth
Revenue 3Y CAGR
FCF Growth7.13%
Safety
Net Debt / EBITDA-0.30
Interest Coverage-10.74
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-158,830.67

Liminatus Pharma, Inc. Class A Common Stock (LIMN) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Liminatus Pharma, Inc. Class A Common Stock (LIMN) stock price today?

As of Dec 16, 2025, 9:00 PM UTC, Liminatus Pharma, Inc. Class A Common Stock (LIMN) stock is trading at $0.7835. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date LIMN stock quotes for informed trading decisions.

What is Liminatus Pharma, Inc. Class A Common Stock's market capitalization?

Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a market capitalization of approximately $21.2M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Liminatus Pharma, Inc. Class A Common Stock's size relative to other companies in the USD market. The market cap figure updates automatically as the LIMN stock price changes.

What is the 52-week range for Liminatus Pharma, Inc. Class A Common Stock stock?

Liminatus Pharma, Inc. Class A Common Stock (LIMN) stock has traded in a 52-week range of $0.614 — $33.66. The 52-week range shows the highest and lowest prices at which LIMN traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Liminatus Pharma, Inc. Class A Common Stock stock price to this range provides context for recent price action.

How much trading volume does Liminatus Pharma, Inc. Class A Common Stock stock have?

Liminatus Pharma, Inc. Class A Common Stock (LIMN) stock recently traded approximately 161.2K shares. Trading volume indicates market liquidity and investor interest in LIMN. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Liminatus Pharma, Inc. Class A Common Stock stock.

Does Liminatus Pharma, Inc. Class A Common Stock pay dividends to shareholders?

Yes, Liminatus Pharma, Inc. Class A Common Stock (LIMN) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Liminatus Pharma, Inc. Class A Common Stock stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Liminatus Pharma, Inc. Class A Common Stock's intraday price range?

Today, Liminatus Pharma, Inc. Class A Common Stock (LIMN) stock has traded in a range of $0.7705 — $0.8351. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring LIMN's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Liminatus Pharma, Inc. Class A Common Stock stock data?

AlphaPilot sources real-time LIMN stock quotes, fundamental financial data, and historical price charts for Liminatus Pharma, Inc. Class A Common Stock from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Liminatus Pharma, Inc. Class A Common Stock stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of LIMN stock performance.